This is the authors' abstract. We don't add key points for this paper.
We have characterized the BRCA1 gene product by using four polyclonal antibodies raised against peptides from four different regions of the protein. The antibodies specifically recognize an approximately 220-kDa BRCA1 protein that is predominantly expressed in the nucleus of both normal and neoplastic breast cancer cells. It is a serine phosphoprotein that undergoes hyperphosphorylation during late G1 and S phases of the cell cycle and is transiently dephosphorylated early after M phase. We propose that BRCA1 is a phosphoprotein that alters in a qualitative and quantitative manner during cell cycle progression.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ruffner et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: